FDA Inspection 867621 — Carter Bloodcare - Allen
The FDA completed an inspection of Carter Bloodcare - Allen on Feb 25, 2014 in Allen, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 25, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Allen, TX (United States)